Attention: This page may not render properly. The browser you are using, Internet Explorer 10, is no longer supported.

Patients
  • Our Medicines
  • Genentech Patient Foundation
  • Clinical Trials
  • Patient Support Services
  • Understanding Insurance
  • Medicine Information Support
  • Giving Patients a Voice
  • Disease Education
Patient Medical Professional
Patients / Our Medicines

Xeloda®
capecitabine

Full Prescribing Information including boxed WARNINGS
Patient Information

  • On April 1, 2022, Cheplapharm Arzneimittel GmbH (“Cheplapharm”) signed an agreement with F. Hoffmann-La Roche Ltd. to acquire the worldwide rights to Xeloda® (capecitabine). Under the terms of the agreement, Cheplapharm will receive product rights for Xeloda® in certain countries worldwide including the USA.

    Beginning April 4, 2023, please direct any clinical product questions to Cheplapharm’s US partner, H2 Pharma, by phone at 1 (334) 647-1947.

    Who should I contact if I have side effect concerns or have an adverse event to report on the product?

    Beginning April 4, 2023, you may contact Cheplapharm’s US partner, H2 Pharma, by phone at 1-866-995-4272 or by email: [email protected] if you have side effect concerns or you would like to report an adverse event. You may also report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

  • For Patients
  • Our Medicines
  • Genentech Patient Foundation
  • Clinical Trials
  • Patient Support Services
  • Understanding Insurance
  • Medicine Information Support
  • Giving Patients a Voice
  • Disease Education
  • About Us
  • Leadership
  • Policy & Advocacy
  • Our Focus on Oncology
  • Awards & Recognition
  • Investors
  • Suppliers
  • CA Transparency in Supply
  • Compliance Overview
  • Contact Us
  • Call Us
  • Email Us
  • Visit us
  • Submit a Medical Inquiry
  • Submit a Media Inquiry
  • For Medical Professionals
  • Our Medicines & Products
  • Our Pipeline
  • Medical Resources
  • Clinical Trial Information
  • Sunshine Act Compliance
  • Product Security
  • For Partners
  • Our Approach
  • What We Are Looking For
  • Partner With Us
  • JPM 2024 | Contact Us
  • Our Stories
  • For Scientists
  • Our Scientists
  • Publications
  • Oncology
  • Immunology
  • Neuroscience
  • Metabolism
  • Infectious Disease
  • Ophthalmology
  • For Media
  • News Features
  • Press Releases
  • Statements
  • Company Information
  • Sign Up For News Alerts
  • For Good
  • Giving
  • Diversity & Inclusion
  • Sustainability
  • Diversity & Inclusion
  • Fostering Belonging
  • Health Equity
  • Advancing Inclusive Research
  • Transforming Society
  • Our 2022 Diversity & Inclusion Report
  • Our 2021 Diversity & Inclusion Report
  • Our Work in Action
  • Kindergarten to Careers
  • Now Hiring
  • Find A Job
  • Professional Areas
  • —
  • Privacy Policy
  • Terms & Conditions
  • Accessibility
© 2023 Genentech, Inc. All rights reserved. This site is intended for US residents only.